2023 AGM discussion and comments, page-407

UBS forecasts Chinese lepidolite production will increase from 130 kt this year to 189 kt in 2024, and 282 kt in 2025. It is going to be the marginal cost of production of Chinese lepidolite producers which largely determines the prevailing price for other lithium minerals in the near term.

UBS pegs this at around 80,000 RMB/t, and speculates that this could translate to a spodumene concentrate 6% price of around US$800/t. To put this into perspective, that’s roughly a little more than half of the current spodumene spot price.

I don't trust banks/analysts but the price continues to collapse, giving them more credence.

SYA would be forced into C&M at that point. Either that or produce product at a significant loss (funded by debt or cap raises). My question is what rights do PLL have if the venture becomes fully unprofitable and we start burning through cash.